| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $0.2 (Miss by $-0.66) |
| EPS GAAP Actual | $0.2 (Miss by $-0.66) |
| Revenue Actual | $3.68077B |
| Revenue Surprise | Beat by $3680.77M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.78 |
| EPS GAAP Estimate | $0.78 |
| Revenue Estimate | $2.3358B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2030 | 6.83 | 6.17 | 6.53372 | 7.078 | 1 |
| Jun 2029 | 6.13 | 6.87 | 5.70922 | 6.89563 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.038 | -1.33133 | 3.68077B | 26.24% | 807.77M |
| FQ2 2025 (Jun 2025) | 0.36 | 0.36 | 2.51205B | -0.51% | 2512.05M |
| FQ1 2025 (Mar 2025) | -0.36 | -1.16 | 3.00913B | 12.67% | 634.33M |
| FQ4 2024 (Dec 2024) | -0.39 | -1.315 | 2.74234B | 24.2% | 386.34M |
| FQ3 2024 (Sep 2024) | 0.39 | 0.39 | 2.7151B | 8.49% | 2715.1M |
| FQ2 2024 (Jun 2024) | 1.25 | 1.25 | 2.52495B | -24.96% | 2524.95M |
| FQ1 2024 (Mar 2024) | 0.22 | 0.22 | 2.628B | 11.83% | 2628M |
| FQ4 2023 (Dec 2023) | 0.6 | 0.6 | 2.07881B | 6.21% | 2078.81M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.78
Consensus Revenue Estimates
2.3358B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Mar 2027) | 0.97 | -- | 0.90532 | 1.05818 | 1 |
| FQ4 2026 (Dec 2026) | 1.05 | -- | 0.97999 | 1.14545 | 1 |
| FQ3 2026 (Jul 2026) | 1.52 | 102.5 | 1.37107 | 1.63957 | 0 |
| FQ1 2026 (Mar 2026) | 0.78 | 146.15 | 0.74879 | 0.84199 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Mar 2027) | 3.03B | -- | 2.88B | 3.25B | 2 |
| FQ4 2026 (Dec 2026) | 3.52B | -- | 3.34B | 3.77B | 1 |
| FQ3 2026 (Jul 2026) | 3.87B | 4.86 | 3.58B | 4.1B | 0 |
| FQ1 2026 (Mar 2026) | 2.34B | -28.83 | 2.26B | 2.48B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.29333 | -0.038 | -1.33133 | 3503.5% |
| FQ2 2025 (Jun 2025) | 0.36 | 0.36 | 100% | |
| FQ1 2025 (Mar 2025) | 0.8 | -0.36 | -1.16 | 322.22% |
| FQ4 2024 (Dec 2024) | 0.925 | -0.39 | -1.315 | 337.18% |
| FQ3 2024 (Sep 2024) | 0.39 | 0.39 | 100% | |
| FQ2 2024 (Jun 2024) | 1.25 | 1.25 | 100% | |
| FQ1 2024 (Mar 2024) | 0.22 | 0.22 | 100% | |
| FQ4 2023 (Dec 2023) | 0.6 | 0.6 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $2.87B | $3.68B | $807.77M | 21.95% |
| FQ2 2025 (Jun 2025) | $0B | $2.51B | $2512.05M | 100% |
| FQ1 2025 (Mar 2025) | $2.37B | $3.01B | $634.33M | 21.08% |
| FQ4 2024 (Dec 2024) | $2.36B | $2.74B | $386.34M | 14.09% |
| FQ3 2024 (Sep 2024) | $0B | $2.72B | $2715.1M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.52B | $2524.95M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.63B | $2628M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $2.08B | $2078.81M | 100% |